Bioxyne Stock

Bioxyne Gross Margin

The Gross Margin of Bioxyne (BXN.AX) as of Aug 9, 2026 is 36.32 %. In the previous year, Gross Margin was 36.44 % — a change of -0.33% (lower).

Gross Margin

36.32 %

YoY

-0.33%

Last updated:

Gross Margin of Bioxyne is 2026 36.32 % . Gross Margin of Bioxyne was 2025 36.44 % . It decreases by -0.33% lower compared to the previous year.

Bioxyne's gross margin stands at 36.3%, down from 51.2% several years earlier.

Access this data via the Eulerpool API

Bioxyne Stock analysis

What does Bioxyne do? Bioxyne Ltd is an Australian biotechnology company that was founded in 2000. Bioxyne's business model focuses on the discovery, development, and marketing of innovative, turnkey biological products and services to improve consumers' health and well-being. Bioxyne has four different business divisions: natural products, health and wellness products, veterinary products, and contract research services. In the natural products division, Bioxyne offers a portfolio of products based on natural ingredients, such as probiotics, superfood powders, herbal extracts, and dietary supplements. These products are designed to strengthen the immune system, promote gut health and digestion, and support a healthy lifestyle. Bioxyne's health and wellness product division offers a wide range of innovative products aimed at improving the health and well-being of people, such as vitamins, dietary supplements, skincare products, and anti-aging products. Bioxyne utilizes the latest biotechnological research to manufacture these products tailored to the needs of customers worldwide. The veterinary product division of Bioxyne is dedicated to improving the health and well-being of pets, livestock, and other animals. Bioxyne offers a wide range of animal health products, including dietary supplements to enhance immune system and skin and hair health, as well as products supporting digestion, metabolism, and cognitive functions in animals. Bioxyne's contract research service division specializes in providing customized and turnkey biological services and products to customers in the pharmaceutical industry, food industry, and veterinary medicine. Bioxyne has an experienced team of scientists and researchers specialized in conducting research and development services in the field of biotechnology. Some of Bioxyne's notable products include the probiotic Nuflora, used to support and improve gut health, the natural dietary supplement Ceramosides, which has strong anti-aging effects due to its formula, and the superfood powder blend Health 365, which contains all the essential nutrients needed to support a healthy lifestyle. Overall, Bioxyne offers a wide range of biotechnological products and services tailored to the needs of customers worldwide. The company is committed to incorporating the latest biotechnological advancements into its products and offering its customers innovative and high-quality solutions to improve health and well-being. Bioxyne is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioxyne stock

Gross Margin of Bioxyne is 36.32 % in 2026.

Gross Margin of Bioxyne changed from 36.44 % to 36.32 %, representing a -0.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Bioxyne since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Bioxyne with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

Margins — Bioxyne

All Key Metrics — Bioxyne